Amanote Research
Register
Sign In
Albania Public Expenditure and Financial Accountability Performance Assessment Report
doi 10.1596/29749
Full Text
Open PDF
Abstract
Available in
full text
Date
December 1, 2017
Authors
Unknown
Publisher
World Bank
Related search
Glucagon-Like Peptide 1 and Glucose-Dependent Insulinotropic Polypeptide Analogues as Novel Treatments for Alzheimer’s and Parkinson’s Disease
Cardiovascular Endocrinology
Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1: Incretin Actions Beyond the Pancreas
Journal of Diabetes Investigation
Internal Medicine
Endocrinology
Metabolism
Medicine
Diabetes
Expression of Glucagon-Like Peptide-1 Receptor and Glucose-Dependent Insulinotropic Polypeptide Receptor Is Regulated by the Glucose Concentration in Mouse Osteoblastic Mc3t3-E1 Cells
International Journal of Molecular Medicine
Medicine
Genetics
Fatty Acid Derivatised Analogues of Glucose-Dependent Insulinotropic Polypeptide With Improved Antihyperglycaemic and Insulinotropic Properties
Biochemical Pharmacology
Biochemistry
Pharmacology
Protective Roles of the Incretin Hormones Glucagon-Like Peptide-1 and Glucose-Dependent Insolinotropic Polypeptide Hormones in Neurodegeneration
Effects of Gastric Inhibitory Polypeptide, Glucagon-Like Peptide-1 and Glucagon-Like Peptide-1 Receptor Agonists on Bone Cell Metabolism
Basic and Clinical Pharmacology and Toxicology
Medicine
Toxicology
Pharmacology
Pancreatic Beta-Cells Are Rendered Glucose-Competent by the Insulinotropic Hormone Glucagon-Like Peptide-1(7-37)
Nature
Multidisciplinary
Chlorogenic Acid Differentially Affects Postprandial Glucose and Glucose-Dependent Insulinotropic Polypeptide Response in Rats
Applied Physiology, Nutrition and Metabolism
Nutrition
Endocrinology
Sports Science
Physiology
Dietetics
Medicine
Metabolism
Diabetes
Glucose-Sensing in Glucagon-Like Peptide-1-Secreting Cells
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Glucagon-Like Peptide Analogues for Type 2 Diabetes Mellitus
